Stephanie Ling is a scientific leader with over nine years of experience in the biopharmaceutical industry. Currently serving as the Director of Discovery Imaging in Integrated Bioanalysis at AstraZeneca since 2024, Stephanie has previously held the roles of Associate Director and Associate Principal Scientist at the same company from 2019 to 2021. Stephanie earned a Master's degree in Biochemistry from the University of Oxford, graduating with First Class Honours in 2011, and later obtained a PhD in Myofibroblast Activation in Pancreatic Cancer from The Institute of Cancer Research in 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices